Literature DB >> 9466779

Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.

R E Edelstein1, D A Nickerson, V O Tobe, L A Manns-Arcuino, L M Frenkel.   

Abstract

This report describes the detection of mutations in the pol gene of human immunodeficiency virus type 1 associated with resistance to zidovudine, didanosine, and lamivudine by genotyping by an oligonucleotide ligation assay specific codons in the pol gene amplified by PCR. Our studies demonstrate the sensitivity, simplicity, and specificity of this genotyping system.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9466779      PMCID： PMC104580     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay.

Authors:  D A Nickerson; R Kaiser; S Lappin; J Stewart; L Hood; U Landegren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  A ligase-mediated gene detection technique.

Authors:  U Landegren; R Kaiser; J Sanders; L Hood
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

4.  Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.

Authors:  L Stuyver; A Wyseur; A Rombout; J Louwagie; T Scarcez; C Verhofstede; D Rimland; R F Schinazi; R Rossau
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes.

Authors:  B A Larder; P Kellam; S D Kemp
Journal:  AIDS       Date:  1991-02       Impact factor: 4.177

6.  Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.

Authors:  B A Larder; P Kellam; S D Kemp
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

7.  Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.

Authors:  L M Frenkel; L E Wagner; S M Atwood; T J Cummins; S Dewhurst
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.

Authors:  J A Zack; A M Haislip; P Krogstad; I S Chen
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

Authors:  A J Japour; D L Mayers; V A Johnson; D R Kuritzkes; L A Beckett; J M Arduino; J Lane; R J Black; P S Reichelderfer; R T D'Aquila
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307
View more
  31 in total

1.  Novel enzyme-linked minisequence assay for genotypic analysis of human immunodeficiency virus type 1 drug resistance.

Authors:  Wataru Sugiura; Kazunori Shimada; Masakazu Matsuda; Tomoko Chiba; Lay Myint; Aiko Okano; Kaneo Yamada
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Authors:  Ingrid A Beck; Minyoung Jang; Jennifer McKernan-Mullin; Marta Bull; Thor Wagner; Sharon Huang; Lin-Ye Song; Sharon Nachman; Paul Krogstad; Susan H Eshleman; Andrew Wiznia; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-27       Impact factor: 2.205

3.  Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.

Authors:  Elias K Halvas; Grace M Aldrovandi; Peter Balfe; Ingrid A Beck; Valerie F Boltz; John M Coffin; Lisa M Frenkel; J Darren Hazelwood; Victoria A Johnson; Mary Kearney; Andrea Kovacs; Daniel R Kuritzkes; Karin J Metzner; Dwight V Nissley; Marek Nowicki; Sarah Palmer; Rainer Ziermann; Richard Y Zhao; Cheryl L Jennings; James Bremer; Don Brambilla; John W Mellors
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.

Authors:  Yolanda Vega; Lucía Pérez-Alvárez; Elena Delgado; Mercedes Muñoz; Gema Casado; Rocío Carmona; María Sierra; Elena Vázquez de Parga; Milagros Pinilla; Valentina García; Leandro Medrano; Gerardo Contreras; Miguel Thomson; Rafael Nájera
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.

Authors:  Jaime Soria; Marta Bull; Caroline Mitchell; Alberto La Rosa; Sandra Dross; Kelli Kraft; Robert Coombs; Eduardo Ticona; Lisa Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

6.  Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

Authors:  Benjamin H Chi; Giovanina M Ellis; Namwinga Chintu; Ronald A Cantrell; Moses Sinkala; Grace M Aldrovandi; Ranjit Warrier; Felistas Mbewe; Kyle Nakamura; Elizabeth M Stringer; Lisa M Frenkel; Jeffrey S A Stringer
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

7.  Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.

Authors:  Ingrid A Beck; Wenjie Deng; Rachel Payant; Robert Hall; Roger E Bumgarner; James I Mullins; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

8.  Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

Authors:  Mark A Micek; Ana Judith Blanco; Ingrid A Beck; Sandra Dross; Laurinda Matunha; Pablo Montoya; Kristy Seidel; Soren Gantt; Eduardo Matediane; Lilia Jamisse; Stephen Gloyd; Lisa M Frenkel
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

9.  Clinical implications of HIV-1 minority variants.

Authors:  Jonathan Z Li; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

10.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.